Micaela Neumann leads strategic communications across global health, innovation, access, and policy priorities. She oversees corporate communications, executive thought leadership, digital platforms, and flagship events that help position the innovative pharmaceutical industry as a key partner in advancing health outcomes, stronger health systems, health security, and economic growth.

Her work spans publications, media relations, social media, executive communications, and high-level convening, bringing together industry leaders, governments, multilateral organizations, and civil society partners. She has led communications and stakeholder engagement strategies around major global health milestones, including the World Health Assembly and United Nations High-Level Meetings, while playing a central role in shaping IFPMA’s evolving narrative, brand, and voice.

Prior to joining IFPMA, Micaela worked with The Lancet and Financial Times Commission on Governing Health Futures 2030, the Union for International Cancer Control (UICC), The Global Fund, Gavi, and Dimagi South Africa. She holds a Master’s degree in Anthropology and Sociology of Development from the Geneva Graduate Institute and a Bachelor’s degree in Communication Studies from the University of Texas at Austin.